These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1489 related articles for article (PubMed ID: 27184250)
1. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review. Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250 [TBL] [Abstract][Full Text] [Related]
2. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]. Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ; Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080 [TBL] [Abstract][Full Text] [Related]
3. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
4. Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease. Florek L; Tiepolt S; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Luthardt J; Sattler B; Patt M; Hoffmann KT; Villringer A; Classen J; Gertz HJ; Sabri O; Barthel H J Alzheimers Dis; 2018; 66(3):1105-1116. PubMed ID: 30400095 [TBL] [Abstract][Full Text] [Related]
6. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype. Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ; J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787 [TBL] [Abstract][Full Text] [Related]
7. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Ewers M; Sperling RA; Klunk WE; Weiner MW; Hampel H Trends Neurosci; 2011 Aug; 34(8):430-42. PubMed ID: 21696834 [TBL] [Abstract][Full Text] [Related]
8. Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer's disease: protocol for a rapid systematic review. Ahmadzadeh M; Christie GJ; Cosco TD; Moreno S Syst Rev; 2020 Apr; 9(1):71. PubMed ID: 32241302 [TBL] [Abstract][Full Text] [Related]
9. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease. Forlenza OV; Diniz BS; Teixeira AL; Stella F; Gattaz W Braz J Psychiatry; 2013; 35(3):284-94. PubMed ID: 24142092 [TBL] [Abstract][Full Text] [Related]
10. A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative. Braskie MN; Thompson PM Biol Psychiatry; 2014 Apr; 75(7):527-33. PubMed ID: 24367935 [TBL] [Abstract][Full Text] [Related]
11. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage. Drago V; Babiloni C; Bartrés-Faz D; Caroli A; Bosch B; Hensch T; Didic M; Klafki HW; Pievani M; Jovicich J; Venturi L; Spitzer P; Vecchio F; Schoenknecht P; Wiltfang J; Redolfi A; Forloni G; Blin O; Irving E; Davis C; Hårdemark HG; Frisoni GB J Alzheimers Dis; 2011; 26 Suppl 3():159-99. PubMed ID: 21971460 [TBL] [Abstract][Full Text] [Related]
12. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593 [TBL] [Abstract][Full Text] [Related]
13. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts. Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z; Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129 [TBL] [Abstract][Full Text] [Related]
14. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia. Román G; Pascual B Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262 [TBL] [Abstract][Full Text] [Related]
15. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts. Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L; Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278 [TBL] [Abstract][Full Text] [Related]
16. A critical discussion of the role of neuroimaging in mild cognitive impairment. Wolf H; Jelic V; Gertz HJ; Nordberg A; Julin P; Wahlund LO Acta Neurol Scand Suppl; 2003; 179():52-76. PubMed ID: 12603252 [TBL] [Abstract][Full Text] [Related]
17. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A; Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis. Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955 [TBL] [Abstract][Full Text] [Related]